News

News Aug 29, 2016 IV stem cell treatment safe, effective in patients with nonischemic HF A single administration of IV allogeneic mesenchymal stem cells was safe and improved certain outcomes in patients with nonischemic HF with reduced ejection fraction, according to the results

News Aug 29, 2016 Cardiocell’s stem cells via IV might be the answer in heart failure Some chronic heart failure (HF) patients given an intravenous injection (IV) of specially prepared stem cells during a small phase IIa study saw significant functional and quality of life

News Aug 29, 2016 VIDEO: Dr. Javed Butler and Dr. C. Michael Gibson Discuss CardioCell Clinical Trial Dr. Javed Butler and Dr. C. Michael Gibson Discuss: Safety and efficacy of intravenous infusion of ischemia tolerant allogeneic mesenchymal stem cells in patients with non-ischemic

News Aug 28, 2016 Stem cells to repair the heart. The enterprise is more difficult than expected The idea is one that could revolutionize the treatment of heart disease: use stem cells to repair the heart in cases where it has been damaged by a heart attack or when it lost its

News Aug 28, 2016 Stem-Cell Therapy Trials Miss Mark but Keep Hope Alive Two stem-cell trials, two negative primary end points, but signals of benefit in each may keep hope alive in patients with heart failure (HF), despite a decade of disappointment in the field. A phase 2a trial

News Aug 28, 2016 Infused stem cells in heart failure: Improved health status but not cardiac function A single dose of mesenchymal stem cells delivered intravenously to patients with chronic non-ischemic cardiomyopathy was not associated with significant cardiac structural or

News Aug 28, 2016 CardioCell To Pursue Large-Scale Chronic Heart Failure Trial For IV Stem Cell Therapy CardioCell has presented data from the first clinical trial to demonstrate the safety and viability of intravenous (IV) ischemia-tolerant mesenchymal stem cells in chronic heart